Koers Chalice Brands Ltd. Canadian Securities Exchange
Aandelen
CHAL
CA15756R1047
Farmaceutische producten
Omzet 2019 | 15,75 mln. 21,65 mln. 14,59 mln. | Omzet 2020 | 21,91 mln. 30,11 mln. 20,29 mln. | Marktkapitalisatie | 20,07 mln. 27,59 mln. 18,58 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -46 mln. -63,22 mln. -42,59 mln. | Nettowinst (verlies) 2020 | -10 mln. -13,74 mln. -9,26 mln. | EV/omzet 2019 | 1,28 x |
Nettoschuld 2019 | 6,22 mln. 8,55 mln. 5,76 mln. | Nettoschuld 2020 | 10,27 mln. 14,11 mln. 9,51 mln. | EV/omzet 2020 | 1,38 x |
K/w-verhouding 2019 |
-0,23
x | K/w-verhouding 2020 |
-1,89
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 78,85% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,24% | 6,06 mld. | |
-22,80% | 4,11 mld. | |
+8,95% | 3,4 mld. | |
-19,98% | 2,81 mld. | |
-10,41% | 2,31 mld. | |
+46,41% | 1,95 mld. | |
+48,31% | 1,53 mld. | |
-15,56% | 1,54 mld. | |
-8,05% | 1,51 mld. |